Learning Objectives
- Describe the major cellular DNA repair pathways—Nucleotide Excision Repair (NER), Base Excision Repair (BER), and Mismatch Repair (MMR)—including their target lesions, enzymatic steps, and cell-cycle timing (
vs.
).
- Correlate specific enzymatic defects in DNA repair pathways with hereditary human syndromes, including Xeroderma Pigmentosum (defective NER excinuclease) and Hereditary Nonpolyposis Colorectal Cancer / Lynch Syndrome (mutated hMSH2 or hMLH1).
- Identify core genomic integrity and DNA damage response genes (DNA polymerases, MSH2/MLH1, XP genes, p53, Rb, ATM, BRCA1/2) and associate their germline mutations with clinical cancer predisposition syndromes (Li-Fraumeni syndrome, Ataxia-telangiectasia, hereditary breast/ovarian cancer).
Cellular DNA is continuously subjected to endogenous metabolic insults (reactive oxygen species, spontaneous deamination, replication errors) and exogenous mutagens (UV radiation, ionizing radiation, chemical carcinogens). High-fidelity repair mechanisms operate predominantly during phase (and
phase for mismatch repair) to excise lesions before S-phase replication locks mutations permanently into the genome.
Major Single-Strand DNA Repair Pathways
| Repair Pathway | Target Lesion & Cell-Cycle Phase | Step-by-Step Enzymatic Mechanism | Associated Human Disease |
|---|---|---|---|
| 1. Nucleotide Excision Repair (NER) |
|
|
Xeroderma Pigmentosum:
|
| 2. Base Excision Repair (BER) |
|
|
Accumulation of point mutations (e.g., |
| 3. Mismatch Repair (MMR) |
|
|
Lynch Syndrome (HNPCC):
|
Genes Maintaining DNA Integrity & Clinical Syndromes
| Genomic Integrity Function | Key Genes / Enzymes | Clinical Correlations & Deficiency Syndromes |
|---|---|---|
| DNA Synthesis Proofreading | Replicative DNA polymerases ( |
Immediate excision of mispaired nucleotides during S phase; loss produces hypermutator phenotypes. |
| Mismatch Repair (MMR) | MSH2, MLH1 | HNPCC (Lynch syndrome): Microsatellite instability; early-onset proximal colon cancer, endometrial cancer, and ovarian cancer. |
| Nucleotide Excision Repair (NER) | XP genes (excinuclease complex) | Xeroderma Pigmentosum: Inability to repair UV-induced pyrimidine dimers; severe photosensitivity and childhood skin malignancies. |
| Cell-Cycle Checkpoint Control | TP53 (p53), RB1 (Rb) | • p53 mutation → Li-Fraumeni syndrome: Autosomal dominant predisposition to multiple early-onset malignancies (sarcomas, breast, brain, adrenal cortical tumors — SBLA). • Rb mutation → Retinoblastoma and osteosarcoma. |
| DNA Damage Sensing & Double-Strand Break Repair | ATM, BRCA1, BRCA2 | • ATM mutation → Ataxia-telangiectasia: Defective sensing of double-strand breaks; cerebellar ataxia, oculocutaneous telangiectasias, IgA deficiency, extreme X-ray (ionizing radiation) sensitivity, and high lymphoma/leukemia risk. • BRCA1/2 mutation: Impaired homologous recombination repair of double-strand breaks; hereditary breast, ovarian, prostate, and pancreatic cancers. |

High-Yield Differential Clues & Diagnostic Pearls
Board-Exam Pattern Recognition Rules
- NER vs. BER Size Distinction: Remember the rule of thumb: Nucleotide excision repair removes an entire oligonucleotide segment containing bulky helix-distorting lesions (like UV-induced thymine dimers), whereas Base excision repair removes a single damaged base (like deaminated cytosine/uracil) via glycosylase and AP endonuclease.
- How Mismatch Repair Identifies the Newly Synthesized Strand: In bacteria, parental DNA strands are methylated at GATC sequences (by Dam methylase), whereas newly synthesized daughter strands are transiently unmethylated—allowing MMR enzymes to selectively excise the error on the new strand.
Ionizing Radiation Sensitivity vs. UV Sensitivity:
- Extreme UV sensitivity: Think Xeroderma Pigmentosum (defective NER of pyrimidine dimers).
- Extreme X-ray / ionizing radiation sensitivity: Think Ataxia-telangiectasia (ATM mutation impairing double-strand break sensing).
Key Points & Memory Hooks:
- Core Rule: NER repairs UV-induced thymine dimers in $G_1$ (defective in Xeroderma Pigmentosum); BER removes deaminated cytosine/uracil via glycosylase and AP endonuclease; MMR fixes replication errors in $G_2$ via MSH2/MLH1 (mutated in Lynch syndrome); and p53, ATM, and BRCA1/2 guard checkpoints and double-strand break repair.
- Memory Hook: “GEL PLease” for Base Excision Repair: Glycosylase, Endonuclease, Lyase, Polymerase, Ligase! “Mismatch = MSH2/MLH1 = Microsatellite instability (Lynch)”; “p53 = Li-Fraumeni; ATM = Ataxia-Telangiectasia”!
Clinical Correlations
Activity
You must be logged in to post a comment.